The Lupus Foundation of America routinely solicits donations from corporations to support its mission and programs that advance research into the causes of and cure for lupus, help raise awareness of lupus, improve the diagnosis and treatment of the disease, and support individuals and families affected by lupus.
The Foundation's board of directors has established a corporate relationships policy to ensure that all corporate support is appropriate and void of potential conflicts of interest. The policy includes a requirement to disclose information on the Foundation's website about corporate support which meets minimum reporting criteria established by the National Health Council and other nonprofit oversight organizations.
Several corporations have provided educational grants and sponsorships for the Lupus Foundation of America's many programs and educational initiatives during the fiscal year ending September 30, 2021 (FY21). In FY21, 16% of the Foundation’s overall revenue came from pharmaceutical, biotechnology, and medical device companies. The Foundation exercises independent judgement in its decision making regardless of any financial support received from these organizations.
Other sources of revenue include: general contributions, foundations, major gifts, special events, planned giving, federal contracts and workplace giving.